Metraipolis › archive › dc_73878ea9e25c
Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes — Europe PMC PMID:42601027
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42601027
- DOI
- 10.1016/j.jped.2026.101597
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T02:45:02.057Z
- SHA-256 of the archived text
e3b0cffa80e5af23f9352a87705c60f4804a3824a6df072263a6708c312bed70- Stable URL of this page
https://metraipolis.com/documento/dc_73878ea9e25c
How to cite
Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes — Europe PMC PMID:42601027 — Europe PMC (en), https://europepmc.org/article/MED/42601027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73878ea9e25c (Metraipolis archive dc_73878ea9e25c, sha256 e3b0cffa80e5af23f9352a87705c60f4804a3824a6df072263a6708c312bed70)
BibTeX
@misc{dc73878ea9e25c,
title = {Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes — Europe PMC PMID:42601027},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42601027},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73878ea9e25c; sha256 e3b0cffa80e5af23f9352a87705c60f4804a3824a6df072263a6708c312bed70},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42601027. Agents can read the archived copy with the MCP tool read_document.